Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992757 · ClinicalTrials.gov registry record
Thromboelastography-derived Functional Fibrinogen Levels
A clinical trial of Focus of Study and Coagulation Status of Cardiac Surgery Patient, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT01992757: Completed study of Focus of Study and Coagulation Status of Cardiac Surgery Patient, sponsored by University of Pennsylvania.
NCT01992757 is a study of Focus of Study and Coagulation Status of Cardiac Surgery Patient that has completed, run by University of Pennsylvania. The registered enrollment target is 51 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992757, a study of Focus of Study and Coagulation Status of Cardiac Surgery Patient, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirements
Primary Outcome
FLEV values obtained during rewarming while on cardiopulmonary bypass (CPB) were compared to FLEV values obtained immediately after CPB and protamine administration. For all patients included, the mean values for rewarming FLEV and mean values for post-CPB FLEV were obtained. If the mean difference for the two timepoints was not statistically different by t-test, then the primary outcome would demonstrate the value of obtaining a rewarming FLEV sample.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-08 |
What the finished NCT01992757 record still lists
NCT01992757 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 3 conditions, with Focus of Study appearing as the primary indexed condition, and to 0 interventions.
NCT01992757 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01992757 about?
NCT01992757 is a clinical study titled "Thromboelastography-derived Functional Fibrinogen Levels". This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirement...
What is the current status of trial NCT01992757?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2013-11. Estimated completion is 2015-08.
What conditions does trial NCT01992757 study?
This clinical trial studies the following conditions: Focus of Study, Coagulation Status of Cardiac Surgery Patient, Reducing Excess Blood Transfusion.
Who is sponsoring clinical trial NCT01992757?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01992757 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia